National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists' practices
- PMID: 21401817
- DOI: 10.3109/13682822.2010.484849
National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists' practices
Abstract
Background: Communication and swallowing changes feature prominently in Parkinson's disease. People with Parkinson's disease appear under-represented in speech-language therapy clinics in the United Kingdom. The nature of the speech-language therapy services in the UK to people with Parkinson's disease has not been examined.
Aims: To ascertain the number of speech-language therapists in the UK who work with people with Parkinson's disease; to establish the nature of contacts in terms of caseloads, referral stages and routes, management practices, assessments and treatments employed; and to reflect on service provision in relation to published guidelines.
Methods & procedures: A questionnaire survey of speech-language therapists.
Outcomes & results: A total of 185 speech-language therapists responded. They were treating a median of three (inter-quartile range (IQR) = 1-6) people with Parkinson's disease with a further median of five (IQR = 1-10) on review. The majority of contacts were for assessment and advice given, especially in later and earlier stages of Parkinson's disease. Typically, respondents offered a median of six sessions (IQR = 6-8) of treatment, each session lasting a median of 45 min (IQR = 45-60), delivered over a median period of 42 days (IQR = 28-56). Speech-language therapists worked in a variety of settings, predominantly hospital. They received referrals principally from medical specialities, from whom the majority had support. Referrals were perceived in general to be later in Parkinson's disease progression than desired. Assessment focused primarily on impairment measures, in contrast to a belief that therapy focus on activity and participation issues. Speech-language therapists were relatively confident in treating people with Parkinson's disease, but 75% wanted more training.
Conclusions & implications: Speech-language therapist services for people with Parkinson's disease in the UK are restricted on most dimensions. Management practices often do not match guideline suggestions. Consideration needs to be given to the training for, content of and delivery of speech-language therapy services for people with Parkinson's disease.
© 2010 Royal College of Speech & Language Therapists.
Similar articles
-
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001. Health Technol Assess. 2024. PMID: 39364774 Free PMC article. Clinical Trial.
-
Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectives.Int J Lang Commun Disord. 2011 Mar-Apr;46(2):179-88. doi: 10.3109/13682822.2010.484850. Int J Lang Commun Disord. 2011. PMID: 21401816
-
Speech and language therapy service delivery for bilingual children: A survey of three cities in Great Britain.Int J Lang Commun Disord. 2006 Nov-Dec;41(6):635-52. doi: 10.1080/13682820600623911. Int J Lang Commun Disord. 2006. PMID: 17079220
-
Speech and language therapy: is it effective?Public Health. 1995 Mar;109(2):143-53. doi: 10.1016/s0033-3506(05)80008-3. Public Health. 1995. PMID: 7716255 Review.
-
Working with culturally and linguistically diverse students and their families: perceptions and practices of school speech-language therapists in the United States.Int J Lang Commun Disord. 2015 Nov-Dec;50(6):750-62. doi: 10.1111/1460-6984.12176. Epub 2015 Jul 27. Int J Lang Commun Disord. 2015. PMID: 26216659 Review.
Cited by
-
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001. Health Technol Assess. 2024. PMID: 39364774 Free PMC article. Clinical Trial.
-
Vowel production: a potential speech biomarker for early detection of dysarthria in Parkinson's disease.Front Psychol. 2023 Aug 28;14:1129830. doi: 10.3389/fpsyg.2023.1129830. eCollection 2023. Front Psychol. 2023. PMID: 37701868 Free PMC article.
-
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7. Trials. 2020. PMID: 32460885 Free PMC article.
-
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).Pilot Feasibility Stud. 2018 Jan 10;4:30. doi: 10.1186/s40814-017-0222-z. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 29344405 Free PMC article.
-
Exploring the Perceptions of Voice-Assisted Technology as a Tool for Speech and Voice Difficulties: Focus Group Study Among People With Parkinson Disease and Their Carers.JMIR Rehabil Assist Technol. 2025 Jul 16;12:e75316. doi: 10.2196/75316. JMIR Rehabil Assist Technol. 2025. PMID: 40669073 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical